drugset / Trial / NCT00040430
Study of 111In-DAC as a Medical Imaging Agent for the Detection of Breast Cancer
Non-randomizedSingle-groupOpen-labelDiagnostic
Summary
The purpose of this study is to investigate the safety and imaging ability of 111In-DAC when used with planar and SPECT imaging for the detection of breast cancer.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 111In-DAC | Diagnostic / imaging agent | — | — |